Bruker Corporation (BRKR:NASDAQ) closed at $55.60 on October 14, 2026, down 1.05% on the day. The stock trades 17.0% below its 52-week high of $66.98 and 71.8% above its 52-week low of $32.37. Over the past year, it gained 53.9%. Bruker Corporation is part of the Capital Goods sector (Biotechnology: Laboratory Analytical Instruments).
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -4.50% | +6.70% | -5.16% | +38.06% | +53.86% |
In 252 trading sessions since October 14, 2025, BRKR closed higher on 120 days (48%). Its best day was May 28, 2026 (+11.87%) and its worst was August 4, 2026 (-21.79%). The stock moved 10% or more in a single session 4 times. It opened at least 5% above the previous day's high 2 times.
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions worldwide. The company operates through two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear and explosive detection in emergency response, homeland security, and defense applications; and analytical and process analysis instruments and solutions. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare, and bi...
Find more stocks like BRKR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.